| Literature DB >> 30898095 |
Pich Seekaew1, Ezie Nguyen2,3, Thanthip Sungsing2, Jureeporn Jantarapakde2, Supabhorn Pengnonyang2, Deondara Trachunthong2, Pravit Mingkwanrungruang2, Waraporn Sirisakyot2, Pattareeya Phiayura2, Phubet Panpet4, Phathranis Meekrua5, Nanthika Praweprai6, Fonthip Suwan7, Supakarn Sangtong8, Pornpichit Brutrat9, Tashada Wongsri10, Panus Rattakittvijun Na Nakorn2, Stephen Mills11, Matthew Avery11, Ravipa Vannakit12, Praphan Phanuphak2, Nittaya Phanuphak2.
Abstract
BACKGROUND: Based on government estimates from the Asian Epidemic Model, new infections among men who have sex with men (MSM) and transgender women (TGW) in Thailand are forecast to proportionally increase over time. Daily oral Pre-exposure prophylaxis (PrEP) protects against HIV acquisition when used as prescribed. The "Princess PrEP" program is the first key population-led (PrEP) initiative under Thai royal patronage with an aim to scale up countrywide implementation of PrEP.Entities:
Keywords: HIV prevention; Key population-led; MSM; PrEP adherence; Pre-exposure prophylaxis; Transgender women
Mesh:
Year: 2019 PMID: 30898095 PMCID: PMC6429797 DOI: 10.1186/s12889-019-6645-0
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Bivariate associations of participant sociodemographics and adherence subgroups among MSM and TGW in the Princess PrEP program (N = 653)
| Variables | Total | Low Adherence: ≤ 3 Pills per week or no show at Month 1 N (%) | Good Adherence: 4–7 Pills per Week N (%) | |
|---|---|---|---|---|
| Total | 653 (100) | 244 (37.4) | 409 (62.6) | |
| Age (years) | ||||
| Mean (SD) | 28.9 (7.3) | 27.8 (7.3) | 29.5 (7.1) | 0.003a |
| Age ≤ 25 | 245 (37.5) | 110 (44.9) | 135 (55.1) | 0.002c |
| Age > 25 | 408 (62.5) | 134 (32.8) | 274 (67.2) | |
| Gender | < 0.001c | |||
| Male | 564 (86.4) | 186 (33.0%) | 378 (67.0) | |
| TGW | 89 (13.6) | 58 (65.2) | 31 (34.8) | |
| Sites | < 0.001c | |||
| Bangkok | 480 (73.5) | 151 (31.5) | 329 (68.5) | |
| Chonburi | 112 (17.2) | 74 (66.1) | 38 (33.9) | |
| Chiang Mai | 36 (5.5) | 6 (16.7) | 30 (83.3) | |
| Songkhla | 25 (3.8) | 13 (52.0) | 12 (48.0) | |
| Nationality | 0.009c | |||
| Thai | 609 (93.3) | 221 (36.3) | 388 (63.7) | |
| Non-Thai | 32 (4.9) | 19 (59.4) | 13 (40.1) | |
| Marital status | 0.66d | |||
| Single | 564 (86.4) | 214 (38.0) | 350 (62.1) | |
| Living together/Married | 64 (9.8) | 24 (37.5) | 40 (62.5) | |
| Divorced/Widow | 6 (0.9) | 1 (16.7) | 5 (83.3) | |
| Education | < 0.001c | |||
| Less than Bachelor degree | 242 (37.1) | 127 (52.5) | 115 (47.5) | |
| Bachelor degree and above | 374 (57.3) | 107 (28.6) | 267 (71.4) | |
| Occupation | < 0.001c | |||
| Unemployed/Student | 119 (18.2) | 42 (35.3) | 77 (64.7) | |
| Employed | 435 (66.6) | 144 (33.1) | 291 (66.9) | |
| Service Worker (beautician, restaurant, etc.) | 87 (13.3) | 54 (62.1) | 33 (37.9) | |
| Monthly Income (THB) | 0.014c | |||
| Less than or equal 10,000 THB | 100 (15.3) | 45 (45.0) | 55 (55.0) | |
| 10,001–20,000 THB | 243 (37.2) | 101 (41.6) | 142 (58.4) | |
| 20,001–50,000 THB | 171 (26.2) | 48 (28.1) | 123 (71.9) | |
| Greater than 50,000 THB | 39 (6) | 15 (38.5) | 24 (61.5) | |
| Have ever had HIV testing/services at clinic before enrollment in this study | 0.17c | |||
| New Client | 539 (82.5) | 208 (38.6) | 331 (61.4) | |
| Yes | 102 (15.6) | 32 (31.4) | 70 (68.6) | |
aStudent’s t-tests/Unpaired t-test
bMann-Whitney/Wilcoxon rank-sum test
cChi square test
dFisher’s Exact test
MSM men who have sex with men, TGW transgender women, THB Thai Baht
Bivariate associations of participant sexual risk behavior and adherence subgroups among MSM and TG (N = 653)
| Variables | Total N (%) | Low Adherence: ≤ 3 Pills per week or no show at month 1 N (%) | Good Adherence: 4–7 Pills per week N (%) | |
|---|---|---|---|---|
| Age at first sexual intercourse (years) | ||||
| Median (IQR) | 18 (16–21) | 18 (15–20) | 18 (16–21) | 0.12a |
| < 18 | 220 (33.7) | 86 (39.1) | 134 (60.9) | 0.19b |
| ≥ 18 | 376 (57.6) | 127 (33.8) | 249 (66.2) | |
| Sexual partners in lifetime | ||||
| Male only | 432 (66.2) | 153 (35.4) | 279 (64.6) | |
| TGW only | 15 (2.3) | 12 (80.0) | 3 (20.0) | |
| Male & Female | 116 (17.8) | 37 (31.9) | 79 (68.1) | |
| Male & TGW | 6 (0.9) | 3 (50.0) | 3 (50.0) | |
| Female & TGW | 5 (0.8) | 1 (20.0) | 4 (80.0) | |
| Male/Female/TGW | 19 (2.9) | 6 (31.6) | 13 (68.4) | |
| HIV perceived risk in the past 3 months | 0.38b | |||
| No risk | 59 (9) | 27 (45.8) | 32 (54.2) | |
| Mild | 217 (33.2) | 75 (34.6) | 142 (65.4) | |
| Moderate | 222 (34) | 81 (36.5) | 141 (63.5) | |
| High | 109 (16.7) | 36 (33.0) | 73 (67.0) | |
| Had sexual intercourse with male partner in past 3 months | 581 (89) | 209 (36.0) | 372 (64.0) | 0.61b |
| Median (IRQ) of male partners | 3 (2–8) | 4 (2–10) | 3 (2–5) | 0.008a |
| Had sexual intercourse with female partner in past 3 months | 43 (6.6) | 20 (46.5) | 23 (53.5) | |
| Median (IRQ) of female partners | 1 (1–3) | 2 (1–3) | 1 (1–3) | |
| Had sexual intercourse with TGW partner in the past 3 months | 16 (2.5) | 7 (43.8) | 9 (56.2) | |
| Median (IRQ) of TG partners | 1 (1–3) | 1.5 (1–4) | 1 (1–2.5) | |
| Number of sexual partners in the past 3 months (all MSM, female and TGW) | 0.09b | |||
| No sexual partner | 17 (2.6) | 8 (47.1) | 9 (52.9) | |
| Single partner | 122 (18.7) | 40 (32.8) | 82 (67.2) | |
| Multiple partners | 418 (64.0) | 146 (34.9) | 272 (65.1) | |
| Had sexual intercourse in the past 3 months but didn’t specify number of sex partners | 51 (7.8) | 26 (51.0) | 25 (49.0) | |
| Number of sex partners in past 3 months (all MSM, female and TGW) (median, IQR) | 3.5 (2–8) | 4 (2–10) | 3 (2–6) | 0.006a |
| Condom use (anal receptive or insertive) in the past 3 months | 0.42b | |||
| Protected sex (No sexual activity + Always) | 285 (43.6) | 96 (33.7) | 189 (66.3) | |
| Unprotected sex (Never + Sometimes) | 276 (42.3) | 102 (37.0) | 174 (63.0) | |
| Substance/stimulant/drug use in the past 3 months | 0.98b | |||
| No | 374 (57.3) | 134 (35.8) | 240 (64.2) | |
| Yes (Overall participants that reported substance/stimulant/drug use at least once) | 221 (33.8) | 79 (35.7) | 142 (64.3) | |
| If “Yes”, substance/stimulant/drug use in the past 3 months | ||||
| Alcohol | 128 (19.6) | 48 (37.5) | 80 (62.5) | |
| Methamphetamine/amphetamine | 33 (5.1) | 12 (36.4) | 21 (63.6) | |
| Ecstasy | 7 (1.1) | 3 (42.9) | 4 (57.1) | |
| Drug Application (Ketamine). | 6 (0.9) | 4 (66.7) | 2 (33.3) | |
| Poppers | 82 (12.6) | 20 (24.4) | 62 (75.6) | |
| Cocaine | 5 (0.8) | 4 (80.0) | 1 (20.0) | |
| Marijuana | 7 (1.1) | 3 (42.9) | 4 (57.1) | |
| Barbiturates or other sedatives | 1 (0.2) | 1 (100.0) | 0 (0) | |
| Viagra or other drugs in same group | 59 (9.0) | 20 (33.9) | 39 (66.1) | |
| Amphetamine-type stimulant used in past 3 months | 0.83b | |||
| No | 571 (87.4) | 206 (36.1) | 365 (63.9) | |
| Yes | 37 (5.7) | 14 (37.8) | 23 (62.2) | |
| Symptoms of STI or previously diagnosed with STI (gonorrhea, chlamydia, herpes, syphilis) in the past 3 months | 0.67b | |||
| None | 472 (72.3) | 170 (36.0) | 302 (64.0) | |
| Yes, have any STI | 68 (10.4) | 22 (32.4) | 46 (67.6) | |
| Unsure | 47 (7.2) | 19 (40.4) | 28 (59.6) | |
| Had group sex in the past 3 months | 0.44b | |||
| No | 435 (66.7) | 150 (34.5) | 285 (65.5) | |
| Yes | 131 (20.1) | 50 (38.2) | 81 (61.8) | |
| Yes, Median (IQR) # of times of group sex | 3 (1–3) | 2.5 (2–3) | 3 (1–3) | 0.88a |
| Yes, Median (IQR) of # of partners during group sex each time | 3 (3–3) | 3 (3–3) | 3 (3–3) | 0.89a |
| If yes, use of condom during group sex | 0.09c | |||
| No | 5 (3.8) | 4 (80.0) | 1 (20.0) | |
| Sometimes | 38 (29.0) | 16 (42.1) | 22 (57.9) | |
| Always | 80 (61.1) | 27 (33.8) | 53 (66.3) | |
| If yes, use of stimulants/drugs before/during group sex | 0.34b | |||
| No | 61 (46.6) | 25 (41.0) | 36 (59.0) | |
| Sometimes | 46 (35.1) | 18 (39.1) | 28 (60.9) | |
| Always | 18 (13.7) | 4 (22.2) | 14 (77.8) | |
aMann-Whitney/Wilcoxon rank-sum test
bChi square test
cFisher’s Exact test
IQR interquartile range, MSM men who have sex with men, TGW transgender women, STI sexually transmitted infection
Binary logistic regression of factors independently associated with low adherence (< 3 pills per week or no show at month 1) among Thai MSM and TGW (N = 653)
| Variables | Univariate | Multivariable | ||||
|---|---|---|---|---|---|---|
| aOR | 95% CI |
| aOR | 95% CI |
| |
| Demographic data | ||||||
| Age (years) | 0.002 | 0.044 | ||||
| Age ≤ 25 | 1.67 | 1.20–2.31 | 1.49 | 1.01–2.21 | ||
| Age > 25 | Ref | – | Ref | – | ||
| Gender | < 0.001 | 0.005 | ||||
| TGW | 3.8 | 2.38–6.08 | 2.2 | 1.27–3.83 | ||
| Male | Ref | – | Ref | – | ||
| Sites | < 0.001 | |||||
| Chiang Mai/Songkhla | 0.99 | 0.55–1.75 | 0.97 | 0 .53–1.79 | 0.924 | |
| Chonburi | 4.24 | 2.74–6.56 | 2.91 | 1.55–5.45 | 0.001 | |
| Bangkok | Ref | – | Ref | – | ||
| Nationality | 0.01 | 0.28 | ||||
| Thai | Ref | – | Ref | – | ||
| Foreigner | 2.57 | 1.24–5.30 | 1.57 | 0.70–3.52 | ||
| Marital status | 0.52 | |||||
| Single | Ref | – | ||||
| Living together/Married | 0.98 | 0.58–1.67 | ||||
| Divorced/Widow | 0.33 | 0.04–2.82 | ||||
| Education* | < 0.001 | |||||
| Less than Bachelor degree | 2.76 | 1.97–3.86 | ||||
| Bachelor degree and above | Ref | – | ||||
| Occupation* | < 0.001 | |||||
| Unemployed/Student | 1.1 | 0.72–1.69 | 0.93 | 0.57–1.52 | 0.76 | |
| Employed | Ref | – | Ref | – | ||
| Service Worker (beautician, restaurant, etc.) | 3.31 | 2.05–5.33 | 1.09 | 0.57–2.10 | 0.92 | |
| Income (THB)* | 0.0029 | |||||
| Less than or equal 20,000 THB | 1.73 | 1.20–2.49 | ||||
| Greater than 20,000 THB | Ref | – | ||||
| Have ever had HIV testing/services at clinic before enrollment in this study | 0.16 | 0.04 | ||||
| New Client | 1.37 | 0.87–2.16 | 1.68 | 1.03–2.76 | ||
| Yes | Ref | – | Ref | – | ||
| Risk behavior at baseline | ||||||
| Age at first sexual intercourse (years) | 0.19 | |||||
| < 18 | 1.26 | 0.89–1.78 | ||||
| ≥ 18 | Ref | – | ||||
| HIV perceive risk in the past 3 months | 0.39 | |||||
| No risk | 1.71 | 0.89–3.28 | ||||
| Mild | 1.07 | 0.66–1.74 | ||||
| Moderate | 1.16 | 0.72–1.89 | ||||
| High | Ref | – | ||||
| Number of sexual partners in the past 3 months (all MSM, female and TG) | 0.93 | |||||
| No sexual partner/Single partner | Ref | – | ||||
| Multiple partners | 1.02 | 0.68–1.52 | ||||
| Number of sex partners in past 3 months (all MSM, female and TG) | 0.27 | |||||
| < 3 | Ref | – | ||||
| ≥ 3 | 1.23 | 0.85–1.80 | ||||
| Condom use (anal receptive or insertive) in the past 3 months | 0.42 | |||||
| Safe sex (No sexual activity + Always) | Ref | – | ||||
| Unprotected sex (Never + Sometimes) | 1.15 | 0.82–1.63 | ||||
| Substance/stimulant/drug use in the past 3 months | 0.98 | |||||
| No | Ref | – | ||||
| Yes (Overall participants that reported substance/stimulant/drug use at least once) | 1 | 0.70–1.41 | ||||
| Amphetamine-type stimulant use in the past 3 months | 0.83 | |||||
| None | Ref | – | ||||
| Yes | 0.93 | 0.47–1.84 | ||||
| Symptoms of STI or previously diagnosed with STI (gonorrhea, chlamydia, herpes, syphilis) in the past 3 months | 0.67 | |||||
| None | Ref | – | ||||
| Yes, have any STI | 0.85 | 0.49–1.46 | ||||
| Unsure | 1.21 | 0.65–2.22 | ||||
| Had group sex in the past 3 months | 0.61 | |||||
| Didn’t have group sex | Ref | – | ||||
| Yes, times of group sex < 3 | 1.27 | 0.56–2.89 | ||||
| Yes, times of group sex ≥3 | 1.15 | 0.74–1.79 | ||||
| If yes, number of partners during group sex | 0.73 | |||||
| Didn’t have group sex | Ref | – | ||||
| Yes, # of sex partners during group sex each time < 3 | 1.27 | 0.56–2.89 | ||||
| Yes, # of sex partners during group sex each time ≥ 3 | 1.15 | 0.74–1.79 | ||||
| If yes, condom usage during group sex | 0.29 | |||||
| Didn’t have group sex | Ref | – | ||||
| None or Sometimes | 1.65 | 0.88–3.11 | ||||
| Always | 0.97 | 0.58–1.60 | ||||
| If yes, substance usage during group sex | 0.61 | |||||
| Didn’t have group sex | Ref | – | ||||
| Never | 1.32 | 0.76–2.28 | ||||
| Sometimes or Always | 1 | 0.57–1.73 | ||||
*Education, occupation, and income were found to have collinearity. Occupation was chosen to include into the final logistic model